INJ weekly outlook: Can the move above all major averages fuel further upside?

Traders Union
All News
Crypto
Injective rises 5.38% this week

Highlights

Injective rose 5.38% over the past week to $8.01, ending near the top of its recent trading range.
The asset remains in a bullish structure with a sustained uptrend confirmed by trend and momentum indicators.
Trading is expected between $7.06 and $9.61 in the next week, with key support at $7.61 and resistance at $8.2.

ETF amendment and mainnet upgrade drive institutional focus this week

Institutional developments took center stage last week as Canary Capital amended its SEC filing for a Staked INJ ETF, building anticipation for greater regulated involvement according to ETHNews. Meanwhile, Injective completed its Meridian Mainnet Upgrade, adding institutional-grade tokenization features and private trading support, Bitget News reported. The newly released whitepaper, highlighted by Coinpedia, recasts the protocol’s focus on tokenized finance, derivatives, and AI-driven trading. Additionally, the Injective Foundation launched the Trench Treasury funding program to back grassroots projects in the ecosystem.

Trend strength confirmed as MACD and ADX sustain bullish signals

The daily chart remains trending with a sustained move higher, supported by a firm trend and 27.73% weekly volatility. MACD continues to indicate strength, while ADX at 32.75 further confirms trend momentum. Immediate support sits at the 20-day moving average at $7.61, with structural resistance marked by the recent weekly high at $8.2. Price action above all major averages underscores ongoing bullish control going into the new week.

Upside bias holds if support is maintained through next week

For the next 7 days, the forecasted range stands between $7.06 and $9.61, with a 55% probability of an increase and 45% probability of a decrease. The base case expects price action to consolidate or build further within this band, anchored by support at $7.61 and capped by resistance at $8.2. A decisive break above $8.2 opens upside toward $9.61, while a retreat below $7.61 could see a move down to the $7.06 area. The current bias is for continuation higher as long as price holds above support.

Sholanke Dele, market strategist, views Injective's steady close near $8 as a reflection of resilient institutional-driven sentiment. He notes that headline events, such as Canary Capital’s Staked INJ ETF amendment and the Meridian Mainnet Upgrade, fueled optimism, but warns the market is still vulnerable to sharp reversals. Daily indicators confirm trend strength, yet he underscores that the base case is for consolidation unless price breaks decisively above the $8.2 resistance. Until $7.61 support fails, the cautious bias leans toward further range-building rather than a breakout. "Base case is consolidation within $7.06 to $9.61 — I’ll stay defensive unless we see clear resolution above $8.2 or below $7.61."

Earlier, analysts noted that Injective was maintaining bullish momentum supported by robust derivatives activity and strategic token rewards. The latest institutional advancements and protocol upgrades reinforce that outlook, with the current scenario highlighting $7.61 as a crucial technical support level for traders to monitor in the near term.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.